World Bulletin/News Desk
Past research suggested people who eat this type of diet have healthier hearts, but those studies couldn't rule out that other health or lifestyle differences had made the difference.
But for the new trial, written up in the New England Journal of Medicine, researchers randomly assigned study volunteers at risk of heart disease to a Mediterranean or standard low-fat diet for five years, allowing the team to single out the effect of diet in particular.
"This is good news, because we know how to prevent the main cause of deaths - that is cardiovascular diseases - with a good diet," said Miguel Angel Martinez-Gonzalez, who worked on the study at the Universidad de Navarra in Pamplona.
He and colleagues from across Spain assigned almost 7,500 older adults with diabetes or other heart risks to one of three groups.
Two groups were instructed to eat a Mediterranean diet - one supplemented with extra-virgin olive oil and the other with nuts, both donated for the study - with help from personalized advice and group meetings. The third study group ate a "control" diet, which emphasized low-far dairy products, grains and fruits and vegetables.
Over the next five years, 288 study participants had a heart attack or stroke, or died of any type of cardiovascular disease.
People on both Mediterranean diets, though, were 28 to 30 percent less likely to develop cardiovascular disease than those on the general low-fat diet, the researchers said.
The new study is the first randomized trial of any diet pattern to show benefit among people initially without heart disease, said Dariush Mozaffarian, who studies nutrition and cardiovascular disease at the Harvard School of Public Health.
It's the blend of Mediterranean diet components, and not one particular ingredient, that promotes heart health, according to Martinez-Gonzalez.
"The quality of fat in the Mediterranean diet is very good," he told Reuters Health. "This good source of calories is replacing other bad sources of calories. In addition, there is a wide variety of plant foods in the Mediterranean diet," he added, including legumes and fruits as desserts.
A new cancer drug will be tested as part of a joint effort by AstraZeneca and Lilly.
Smart technology and regulation will aid challenges in global power sector, helping to lower the carbon emitted globally.
A deal between the richest nations in the world has been seen as unlikely, as OECD seeks to phase out export credits.
Soon more than 1 billion consumers in developing nations will be able to buy their first air conditioner, increasing energy demand which will impact global warming
The European Union has given new authorization for 10 new types of genetically modified crops have been approved for a 10 year use for human consumption and animal feed.
Guinea's President Alpha Conde announced new emergency measures in Ebola fight on Saturday
'Meetings happened. Action didn’t,' says Medecins Sans Frontieres report.
WHO said that on many levels, the world is better prepared now than ever before for aflu pandemic
Myanmar health officals say an outbreak of H5N1 bird flu in Mandalay
Tokyo Electric said it has been aware since last spring that radiation levels in water running in one of the plant gutters rise when it rains
Safe drinking water is available at about one-third of the level it was before the conflict erupted nearly five years ago, and supplies are cut-off to punish civilians at times
Elephants in Angola, which suffered decades of civil war, have been observed avoiding heavily-mined areas, suggesting their trunks were warning them to stay away.
Favipiravir halved death rate among some to 15 pct, but WHO says more research required on drug
The first medicine containing stem cells to treat a rare condition caused by burns to the eye has approved.
940 parasite samplescollected at 55 malaria treatment centres across Myanmar and its border regions. They found that almost 40 percent of the samples had mutations in their so-called kelch gene, K13 -- a known genetic signal of artemisinin drug resistance.
Yaws is known to be prevalent in 12 countries in areas where people have little access to healthcare, mainly in West and Central Africa, Asia and the Pacific Islands.